Cuando sus pacientes necesitan de una prueba confiable y rápida, cambie por el kit BD para Detección Rápida de SARS CoV-2. El kit ofrece una prueba fácil de realizar en el punto de atención al paciente con resultados en 15 minutos.
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Experts from around the globe describe the intersection between patient and healthcare worker safety, focusing on techniques to improve both occupational and public health.
Webinar Objectives:
- Describe the current global impact of bloodborne disease
- Describe occupational exposure incidents for needlesticks and sharps injuries
- Define safety as a function of focus for both patient and health worker, to reduce overall bloodborne disease
- Provide guidance on the importance of prevention programs including use of safer medical devices, immunization/vaccination programs, and safe clinical practices
- Illustrate an effective pathway for reporting exposure incidents and injuries
- Define processes for post-exposure medical treatment and prophylaxis
- Share global experiences from key stakeholders responsible for sharps safety and public health programs around the world
Save Your Seat
Los resultados negativos no descartan una infección por SARS-CoV-2 y no deben ser utilizados como única base para el tratamiento y decisiones para el manejo del paciente. Los resultados negativos deben ser considerados en el contexto de las exposiciones recientes del paciente, su historia clínica y la prevalencia de signos y síntomas consistentes con COVID-19, y ser confirmados con una prueba molecular, de ser necesario para el manejo del paciente.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Video title here
¡Solicita más información!
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
El kit BD para Detección Rápida de SARS-CoV-2 en el punto de atención del paciente.
El kit de prueba fácil de usar que provee el resultado de SARS-CoV-2 en 15 minutos.
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Prueba rápida para detección de SARS-CoV-2
Test de antígeno BD de lectura visual fácil de realizar en el punto de atención al paciente con resultados en 15 minutos.¹
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Ibus exped et ape
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Let's have a conversation
Los resultados negativos no descartan una infección por SARS-CoV-2 y no deben ser utilizados como única base para el tratamiento y decisiones para el manejo del paciente. Los resultados negativos deben ser considerados en el contexto de las exposiciones recientes del paciente, su historia clínica y la prevalencia de signos y síntomas consistentes con COVID-19, y ser confirmados con una prueba molecular, de ser necesario para el manejo del paciente.
REFERENCIAS
1. BD Kit for Rapid Detection of SARS-CoV-2 [package insert]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2021
BD Chile Av. Andrés Bello 2325 - piso 15, Tel: (+56 2) 2482 7800, Providencia, Santiago, Chile.
BD Argentina Av. del Libertador 110 - 2° Piso, Tel: (+54 9 11) 5194 4936, Vicente López, Buenos Aires, Argentina.
*Consultar disponibilidad en región.
Argentina: El Producto BD SARS-CoV-2 se encuentra autorizado por ANMAT para COVID-19. USO PROFESIONAL EXCLUSIVO.
ARGENTINA
|
||||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|||||||
CHILE |
||||||||||||||
 |
 |
 |
 |
 |
||||||||||